Literature DB >> 27317008

Validity and Reproducibility of the Glittre ADL-Test in Obese and Post-Bariatric Surgery Patients.

Fabiane Monteiro1, Diego Augusto Nascimento Ponce1, Humberto Silva1, Alexandre Faria Carrilho1, Fabio Pitta2.   

Abstract

BACKGROUND: Obese and post-bariatric surgery (BS) subjects often present limitations in physical functioning (PF). The Glittre ADL-test is a simple and useful way to evaluate this outcome. It includes functional activities such as rising from a chair, lifting, carrying weights, and bending over and was never studied in the obese population. This study aimed to determine the validity and reproducibility of the Glittre ADL-test to evaluate PF in obese, post-BS, and healthy control subjects.
METHODS: Twenty-one post-BS patients (3-4 years post-surgery) (16 women, 41 ± 11 years, BMI = 28 ± 4 kg m-2) (group PO); 21 obese individuals (16 women, 44 ± 9 years, BMI = 44 ± 6 kg.m-2) (group OB) and 21 control individuals matched to PO (16 women, 42 ± 12 years old, BMI = 27 ± 6 kg m-2) (group MC) were included. For the reproducibility analysis, the Glittre ADL-test was performed twice, with a 30-min interval. As criterion methods for the validation, subjects performed two walking tests and answered a health status questionnaire (SF-36).
RESULTS: High intraclass correlation (OB: r = 0.91 and PO: r = 0.89; MC: r = 0.86; P < 0.0001 for all) and good Bland-Altman agreement between the two tests were found in all groups. However, learning effect ranged between 8.8 and 11.8 % and significant test-retest differences occurred. The test was valid for all groups (moderate-to-high significant correlations with the criterion methods).
CONCLUSIONS: Glittre ADL-test is valid and reproducible to evaluate PF of obese, post-BS, and healthy control subjects. However, due to the large learning effect, two tests are required for accurate assessment.

Entities:  

Keywords:  Activities of daily living; Motor activity; Obesity; Physical analysis; Physical fitness

Mesh:

Year:  2017        PMID: 27317008     DOI: 10.1007/s11695-016-2244-7

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  10 in total

1.  Outcome Measures in Cardiopulmonary Physical Therapy: Focus on the Glittre ADL-Test for People with Chronic Obstructive Pulmonary Disease.

Authors:  Gail Dechman; Susan A Scherer
Journal:  Cardiopulm Phys Ther J       Date:  2008-12

2.  SAGES guideline for clinical application of laparoscopic bariatric surgery.

Authors: 
Journal:  Surg Obes Relat Dis       Date:  2009-02-23       Impact factor: 4.734

3.  Gait cinematic analysis in morbidly obese patients.

Authors:  Shirley Aparecida Fabris de Souza; Joel Faintuch; Antonio Carlos Valezi; Antonio Fernando Sant' Anna; Joaquim José Gama-Rodrigues; Inês Cristina de Batista Fonseca; Roger Burgo Souza; Roger Christian Senhorini
Journal:  Obes Surg       Date:  2005-10       Impact factor: 4.129

Review 4.  An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease.

Authors:  Anne E Holland; Martijn A Spruit; Thierry Troosters; Milo A Puhan; Véronique Pepin; Didier Saey; Meredith C McCormack; Brian W Carlin; Frank C Sciurba; Fabio Pitta; Jack Wanger; Neil MacIntyre; David A Kaminsky; Bruce H Culver; Susan M Revill; Nidia A Hernandes; Vasileios Andrianopoulos; Carlos Augusto Camillo; Katy E Mitchell; Annemarie L Lee; Catherine J Hill; Sally J Singh
Journal:  Eur Respir J       Date:  2014-10-30       Impact factor: 16.671

5.  A field test of functional status as performance of activities of daily living in COPD patients.

Authors:  Siri Skumlien; Turid Hagelund; Oystein Bjørtuft; Morten Skrede Ryg
Journal:  Respir Med       Date:  2005-06-06       Impact factor: 3.415

6.  Shuttle walking test in obese women: test-retest reliability and concurrent validity with peak oxygen uptake.

Authors:  Soraia P Jürgensen; Renata Trimer; Victor Z Dourado; Luciana Di Thommazo-Luporini; José C Bonjorno-Junior; Cláudio R Oliveira; Ross Arena; Renata G Mendes; Audrey Borghi-Silva
Journal:  Clin Physiol Funct Imaging       Date:  2014-03-03       Impact factor: 2.273

7.  Physical activity and physical function changes in obese individuals after gastric bypass surgery.

Authors:  Deborah A Josbeno; John M Jakicic; Andrea Hergenroeder; George M Eid
Journal:  Surg Obes Relat Dis       Date:  2008-08-14       Impact factor: 4.734

8.  The six-minute walk test in outpatients with obesity: reproducibility and known group validity.

Authors:  Ulla Evers Larsson; Signy Reynisdottir
Journal:  Physiother Res Int       Date:  2008-06

9.  Reproducibility of the 6-minute walk test in obese adults.

Authors:  K Beriault; A C Carpentier; C Gagnon; J Ménard; J-P Baillargeon; J-L Ardilouze; M-F Langlois
Journal:  Int J Sports Med       Date:  2009-07-07       Impact factor: 3.118

10.  Reproducibility of the six-minute walk test and Glittre ADL-test in patients hospitalized for acute and exacerbated chronic lung disease.

Authors:  Anderson José; Simone Dal Corso
Journal:  Braz J Phys Ther       Date:  2015-05-29       Impact factor: 3.377

  10 in total
  3 in total

1.  Physical Function, Quality of Life, and Energy Expenditure During Activities of Daily Living in Obese, Post-Bariatric Surgery, and Healthy Subjects.

Authors:  Fabiane Monteiro; Diego A N Ponce; Humberto Silva; Fabio Pitta; Alexandre J F Carrilho
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

2.  Reliability and validity of the Glittre-ADL test to assess the functional status of patients with interstitial lung disease.

Authors:  Hellen Fontão Alexandre; Katerine Cristhine Cani; Juliana Araújo; Anamaria Fleig Mayer
Journal:  Chron Respir Dis       Date:  2021 Jan-Dec       Impact factor: 2.444

3.  Development of the impact of weight on daily activities questionnaire: A patient-reported outcome measure.

Authors:  Claire M Ervin; Diane Whalley; Lisa von Huth Smith; Rebecca Crawford; Jennifer Dine; Sheri E Fehnel
Journal:  Clin Obes       Date:  2020-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.